ENDOR AG/ DE0005491666 /
| 2024-08-02 11:39:40 AM | Chg. -0.016 | Volume | Bid6:23:25 PM | Ask6:23:25 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 0.232EUR | -6.45% | 14,200 Turnover: 3,070 |
-Bid Size: - | -Ask Size: - | 3.6 mill.EUR | - | 1.16 |
GlobeNewswire
03-28
CIO Leadership: Celebrating Charlie Feld and Other Recipients of HMG Strategy’s Global Leadership In...
GlobeNewswire
2020-05-01
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
2020-04-28
Rigrodsky & Long, P.A. Files Class Action Suit Against Neon Therapeutics, Inc.
GlobeNewswire
2020-04-24
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
2020-04-17
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, MSBF, QUMU and SBBX Shareholders About Its Ongoing Inv...
GlobeNewswire
2020-03-02
Neon Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business ...
GlobeNewswire
2020-01-16
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
GlobeNewswire
2020-01-16
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
